KR102784679B1 - 분무 용액의 연속적인 제조를 사용한 분무 건조 방법 - Google Patents

분무 용액의 연속적인 제조를 사용한 분무 건조 방법 Download PDF

Info

Publication number
KR102784679B1
KR102784679B1 KR1020207026942A KR20207026942A KR102784679B1 KR 102784679 B1 KR102784679 B1 KR 102784679B1 KR 1020207026942 A KR1020207026942 A KR 1020207026942A KR 20207026942 A KR20207026942 A KR 20207026942A KR 102784679 B1 KR102784679 B1 KR 102784679B1
Authority
KR
South Korea
Prior art keywords
spray
suspension
solvent
manufacturing
buffer tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207026942A
Other languages
English (en)
Korean (ko)
Other versions
KR20200123452A (ko
Inventor
조아오 비센테
코우토 클라라 사
루이 페레이라
마르시오 템템
Original Assignee
호비온 사이언티아 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호비온 사이언티아 리미티드 filed Critical 호비온 사이언티아 리미티드
Publication of KR20200123452A publication Critical patent/KR20200123452A/ko
Application granted granted Critical
Publication of KR102784679B1 publication Critical patent/KR102784679B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/005—Drying solid materials or objects by processes not involving the application of heat by dipping them into or mixing them with a chemical liquid, e.g. organic; chemical, e.g. organic, dewatering aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020207026942A 2018-02-22 2019-02-22 분무 용액의 연속적인 제조를 사용한 분무 건조 방법 Active KR102784679B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT110585 2018-02-22
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
PCT/GB2019/050495 WO2019162688A1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution

Publications (2)

Publication Number Publication Date
KR20200123452A KR20200123452A (ko) 2020-10-29
KR102784679B1 true KR102784679B1 (ko) 2025-03-21

Family

ID=65729388

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207026942A Active KR102784679B1 (ko) 2018-02-22 2019-02-22 분무 용액의 연속적인 제조를 사용한 분무 건조 방법

Country Status (10)

Country Link
US (1) US11752105B2 (https=)
EP (1) EP3755307B1 (https=)
JP (1) JP7481259B2 (https=)
KR (1) KR102784679B1 (https=)
CN (1) CN111954520A (https=)
AU (1) AU2019224665B2 (https=)
CA (1) CA3091546C (https=)
IL (1) IL276826B2 (https=)
PT (1) PT110585B (https=)
WO (1) WO2019162688A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT110585B (pt) 2018-02-22 2021-04-22 Hovione Farmaciencia Sa Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
US12466883B1 (en) 2024-05-13 2025-11-11 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance
WO2026013055A1 (en) 2024-07-09 2026-01-15 Hovione Farmaciência S.A., Methods and systems for preparing feed solutions for spray drying

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513474A (ja) 2006-12-22 2010-04-30 ユーハン・コーポレイション レバプラザン含有の固体分散体及びその製造方法
WO2016156841A1 (en) * 2015-03-31 2016-10-06 Hovione Scientia Limited Continuous production of particles
WO2017129988A1 (en) * 2016-01-28 2017-08-03 Hovione Scientia Limited Continuous complexation of active pharmaceutical ingredients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5222807A (en) 1991-03-12 1993-06-29 Gaco Manufacturing Division Of Gaddis Petroleum Corporation Low shear polymer dissolution apparatus
FI98892C (fi) 1994-11-15 1997-09-10 Turun Asennusteam Oy Polymeerien liuotusmenetelmä ja -laite
CA2299284C (en) 1997-08-05 2008-07-08 Mfic Corporation Multiple stream high pressure mixer/reactor
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
CN105142767B (zh) 2013-03-14 2017-12-12 艺康美国股份有限公司 聚合物溶解系统
KR20160120739A (ko) * 2014-02-11 2016-10-18 램 테라퓨틱스, 인코포레이티드 림프관평활근종증의 치료를 위한 라파마이신
PL3166986T3 (pl) * 2014-07-10 2023-07-31 Huntsman Petrochemical Llc Kompozycja zmniejszająca ilość aldehydów emitowanych z pianek poliuretanowych
PT107846B (pt) * 2014-08-01 2019-03-22 Hovione Farm S A Produção de nano- partículas de dispersões sólidas amorfas por co-precipitação controlada
US9432572B2 (en) * 2014-12-01 2016-08-30 Here Global B.V. Method and apparatus for automatic prediction of dynamic exposure
PT110585B (pt) 2018-02-22 2021-04-22 Hovione Farmaciencia Sa Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513474A (ja) 2006-12-22 2010-04-30 ユーハン・コーポレイション レバプラザン含有の固体分散体及びその製造方法
WO2016156841A1 (en) * 2015-03-31 2016-10-06 Hovione Scientia Limited Continuous production of particles
WO2017129988A1 (en) * 2016-01-28 2017-08-03 Hovione Scientia Limited Continuous complexation of active pharmaceutical ingredients

Also Published As

Publication number Publication date
CN111954520A (zh) 2020-11-17
WO2019162688A1 (en) 2019-08-29
IL276826B1 (en) 2024-10-01
CA3091546A1 (en) 2019-08-29
EP3755307A1 (en) 2020-12-30
IL276826A (en) 2020-10-29
EP3755307C0 (en) 2023-08-23
PT110585B (pt) 2021-04-22
KR20200123452A (ko) 2020-10-29
PT110585A (pt) 2019-08-22
EP3755307B1 (en) 2023-08-23
US20210077405A1 (en) 2021-03-18
US11752105B2 (en) 2023-09-12
IL276826B2 (en) 2025-02-01
AU2019224665A1 (en) 2020-11-26
JP2021514954A (ja) 2021-06-17
CA3091546C (en) 2024-11-12
AU2019224665B2 (en) 2024-09-05
JP7481259B2 (ja) 2024-05-10

Similar Documents

Publication Publication Date Title
JP7203078B2 (ja) 粒子の連続製造方法
Kankala et al. Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds
Dalvi et al. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation
KR102784679B1 (ko) 분무 용액의 연속적인 제조를 사용한 분무 건조 방법
CN105125502A (zh) 制备具有低粒度的药物活性成分的方法
Gao et al. Crystallization methods for preparation of nanocrystals for drug delivery system
US7279181B2 (en) Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
Wang et al. Microparticle formation of sodium cellulose sulfate using supercritical fluid assisted atomization introduced by hydrodynamic cavitation mixer
US20160228373A1 (en) Synthesis and Particle Engineering of Cocrystals
JP2021514954A5 (https=)
Tan et al. Particle formation using supercritical fluids: pharmaceutical applications
ES2964411T3 (es) Un proceso de secado por pulverización con preparación continua de solución de pulverización
JPWO2019162688A5 (https=)
KR101342119B1 (ko) 디올 화합물을 이용한 나노수준의 활성물질 입자 제조 방법
KR101342121B1 (ko) 저온 및 저압 하에서 초임계유체를 이용한 나노수준의활성물질 입자 제조방법
ES2988334T3 (es) Producción continua de partículas
EP3804703A1 (de) Verfahren zur herstellung eines nanopartikulären wirkstoffs
CN101375825A (zh) 一种制备微粉化药物的设备
CN113813238A (zh) 一种超声协同高压均质技术制备芹菜素超细颗粒的方法
BR102017015979A2 (pt) Processo de secagem por atomização utilizando a preparação contínua de soluções com compostos com baixa solubilidade e/ou baixa estabilidade

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200918

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20211223

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240201

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20241007

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

PX0701 Decision of registration after re-examination

Patent event date: 20250107

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250317

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250317

End annual number: 3

Start annual number: 1

PG1601 Publication of registration